CXCL9 and type 2 diabetes mellitus: As with cytokines, MDMs derived from patients with T2D display a tendency to secrete higher levels of chemokines, such as IL-8, MCP-1, MIG, and RANTES under basal conditions, as compared to MDMs from control subjects.